S. R. Schill & Associates Abbott Laboratories Transaction History

S. R. Schill & Associates

$141 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 15, 2024	SELL	$100.73 - $112.44 $184,537 - $205,990	-1,832 Reduced 42.39%	2,490 $258,000
Q1 2024 Apr 04, 2024	BUY	$109.52 - $120.96 $209,621 - $231,517	1,914 Added 79.49%	4,322 $491,000
Q4 2023 Jan 29, 2024	SELL	$90.19 - $110.4 $270,660 - $331,310	-3,001 Reduced 55.48%	2,408 $265,000
Q3 2023 Oct 24, 2023	BUY	$95.53 - $114.62 $95 - $114	1 Added 0.02%	5,409 $523,000
Q1 2023 Apr 26, 2023	SELL	$96.86 - $114.01 $447,880 - $527,182	-4,624 Reduced 46.09%	5,408 $547,000
Q4 2022 Jan 25, 2023	BUY	$95.06 - $111.52 $198,580 - $232,965	2,089 Added 26.3%	10,032 $0
Q3 2022 Oct 26, 2022	SELL	$96.76 - $112.03 $77,214 - $89,399	-798 Reduced 9.13%	7,943 $769,000
Q2 2022 Aug 31, 2022	BUY	$102.07 - $123.37 $98,089 - $118,558	961 Added 12.35%	8,741 $950,000
Q1 2022 May 06, 2022	SELL	$114.02 - $139.04 $291,321 - $355,247	-2,555 Reduced 24.72%	7,780 $921,000
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $4,390 - $5,375	-38 Reduced 0.37%	10,335 $1.46 Million
Q3 2021 Oct 25, 2021	SELL	$116.66 - $129.06 $249,302 - $275,801	-2,137 Reduced 17.08%	10,373 $1.23 Million
Q2 2021 Aug 17, 2021	BUY	$105.79 - $124.53 $60,406 - $71,106	571 Added 4.78%	12,510 $1.45 Million
Q1 2021 Apr 30, 2021	BUY	$108.84 - $128.23 $183,504 - $216,195	1,686 Added 16.44%	11,939 $1.43 Million
Q4 2020 Jan 27, 2021	BUY	$105.0 - $114.42 $116,340 - $126,777	1,108 Added 12.12%	10,253 $1.12 Million
Q3 2020 Nov 18, 2020	SELL	$91.64 - $111.29 $225,434 - $273,773	-2,460 Reduced 21.2%	9,145 $995,000
Q2 2020 Jul 30, 2020	SELL	$76.57 - $98.0 $68,223 - $87,318	-891 Reduced 7.13%	11,605 $1.06 Million
Q1 2020 May 04, 2020	BUY	$62.82 - $91.86 $393,001 - $574,676	6,256 Added 100.26%	12,496 $986,000
Q2 2019 Aug 19, 2019	BUY	$72.88 - $85.0 $454,771 - $530,400	6,240 New	6,240 $525,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.8 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15.5 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$9.05 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.76 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.29 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of S. R. Schill & Associates, based on Form 13F filings with the SEC.

News

Stay updated on S. R. Schill & Associates with notifications on news.

Account